The aim of this study was to investigate possible causes of the pervasiveness of chicken infectious anemia virus (CIAV) infection in chickens in recent years in China. A total of 14 batches of live-virus vaccines were examined using PCR to detect CIAV contamination, of which only 2 samples (a Newcastle disease vaccine and a fowl pox vaccine) tested positive for CIAV. These Newcastle and fowl pox vaccines were then inoculated into 1-day-old specificpathogen-free chickens. Serum samples were collected from chickens infected with the PCR-positive vaccines, and these tested positive for CIAV-specific antibodies as tested using ELISA. In addition, DNA samples isolated from the serum samples also tested positive by PCR. The results indicated that the samples were contaminated with CIAV and identified 2 exogenous CIAV strains, designated CIAV-N22 and CIAV-F10, in the respective samples. The full genome sequences of these novel CIAV strains were sequenced and analyzed. Phylogenetic tree analysis indicated that the CIAV-F10 strain might represent a recombinant viral strain arising from the parental CIAV strains JQ690762 and KJ728816. Overall, the results suggested that vaccination with CIAV-contaminated vaccines contributed to the prevalence and spread of CIAV infection in chickens. Furthermore, the CIAV contaminant was likely subsequently transmitted to commercial chickens through congenital transmission. Our findings therefore highlight the need for more extensive screening of live-virus vaccines for poultry in China to reduce the threat of contamination with exogenous viruses.
INTRODUCTION
Chicken infectious anemia virus (CIAV) is an economically important pathogen that has been commonly identified in chicken populations worldwide (Rosenberger and Cloud, 1989; Zhou et al., 1996; Ducatez et al., 2006; Natesan et al., 2006; Craig et al., 2009; Kim et al., 2010; Zhang et al., 2013) since it was first discovered in Japan in 1979 from contaminated vaccines (Yuasa et al., 1979) . CIAV can cause the atrophy of bone marrow hematopoietic tissue and lymphatic tissues (e.g., thymus) in young chickens, leading to anemia and immune suppression (Taniguchi et al., 1982) . CIAV is important both clinically and subclinically and can be spread both horizontally and vertically (Jørgensen et al., 1995; Todd, 2000) .
CIAV is the only member of the genus Gyrovirus in the family Circoviridae (Natesan et al., 2006) . It is a non-enveloped, icosahedral virus approximately C 2016 Poultry Science Association Inc. Received April 14, 2016. Accepted October 15, 2016. 1 These authors have contributed equally to this work. 2 Corresponding authors: changshuang81@126.com (SC); zhao peng@sdau.edu.cn (PZ) 25 to 35 nm in diameter, with a negative-sense, single-stranded, circular DNA complete genome sequence approximately 2,298 to 2,319 nucleotides in length (Ducatez et al., 2006) . The genome has 3 open reading frames encoding the viral proteins VP1, VP2, and VP3, respectively (Noteborn et al., 1991) , of which VP1 and VP2 comprise protective antigen proteins that induce virus-neutralizing antibodies (Koch et al., 1995) . The amino acid composition of CIAV is highly conservative, with only VP1 displaying variability in certain regions (amino acid positions 139 through 151).
In the present study, we screened locally produced and imported live-virus vaccines used in poultry production for the presence of CIAV. We also determined the phylogenetic relationship between the contaminating CIAV and various CIAV reference strains based on the complete genome sequence.
MATERIALS AND METHODS

Ethics Statement
The study protocol and all animal studies were approved by the Shandong Agricultural University Animal Care and Use Committee. 1045
Live Vaccine Samples
To control the spread and dissemination of exogenous viruses, the Ministry of Agriculture of the People's Republic of China requests that all vaccines to be tested for exogenous viruses before marketing. To identify if any exogenous CIAV existed in live-virus vaccines, 14 batches of live-virus vaccines, including 4 fowl pox virus (FPV) vaccines of the quail attenuated strain, 3 Marek's disease virus (MDV) vaccines of the CVI988 strain, 4 Newcastle disease virus (NDV) livevirus vaccines of the LaSota strain, and 3 infectious Bursal disease virus (IBDV) live-virus vaccines of the B87 strain, were tested.
DNA Extraction and Detection
Genomic DNA was extracted from 14 live-virus vaccine samples using a commercial TIANamp Genomic DNA Kit (Tiangen Biotech Co., Ltd., Tiangen, China) according to the manufacturer's instructions. The extracted DNAs were stored at −20
• C. For all samples, 842 bp of the partial coding regions of CIAV was amplified using the primers CIAV-FP (5 -GCA TTC CGA GTG GTT ACT ATT CC-3 ) and CIAV-RP (5 -CGT CTT GCC ATC TTA CAG TCT TAT-3 ). Polymerase chain reaction (PCR) amplifications were performed in a 25 μL reaction volume containing 0.5 μL forward primer, 0.5 μL reverse primer, 1 μL DNA, 2.5 μL 10× PCR buffer (Mg2 + ), 2 μL dNTPs (2.5 mM), 0.5 μL rTaq DNA polymerase (TaKaRa Biotechnology Co. Ltd., Dalian, China), and an appropriate volume of double-distilled H 2 O. PCR amplification of the product was performed under the following reaction conditions: pre-denaturation at 95
• C for 5 min, denaturation at 95
• C for 30 s, annealing at 55 • C for 50 s, and extension at 72
• C for 60 s, with 30 cycles total and a final extension at 72
• C for 10 min terminated at 4 • C. PCR products were analyzed by 1% agarose gel electrophoresis. Positive and negative controls were included for each sample PCR.
Testing of Live Vaccines for CIAV Contamination by Specific Pathogen Free (SPF) Chicken Inoculation
One-day-old SPF chickens were obtained from SPAFAS Co. (Jinan, China; a joint venture with Charles River Laboratory, Wilmington, MA). We divided 30 SPF chickens into 3 groups that were placed in separated isolators receiving filtered positivepressure air. The live-virus vaccine samples suspected to carry CIAV contamination were each inoculated into 10 1-day-old SPF chickens (0.2 mL inoculum per chicken subcutaneously). Chickens from the negative control group were also inoculated subcutaneously with phosphate-buffered saline as a negative control. Serum samples were collected at 6 wk post-inoculation and tested for anti-CIAV antibodies using commercial enzyme-linked immunosorbent assay (ELISA) kits (Chicken Infectious Anemia Virus Antibody Test Kit, IDEXX Laboratories, Inc., Westbrook, ME) according to the manufacturer's instructions. In addition, the presence of CIAV in the DNA samples extracted from blood plasma was detected using PCR as described below. Each sample was tested in duplicate to ensure accurate test results.
DNA Amplification and Sequencing
We designed 3 pairs of primers according to the CIAV sequences published in GenBank (Table 1) using DNAStar 6.0 to generate 843-, 989-, and 802-bp PCR amplification fragments covering the entire CIAV genome. PCR amplification was carried out in 50 μL reactions containing 25 μL buffer I, 16 μL dNTPs, 0.5 μL each primer, 13.5 μL distilled water, 1 μL the DNA, and 0.5 μL LA Taq polymerase (TaKaRa Bio Inc., Otsu, Japan). All PCR amplification products were analyzed by agarose gel electrophoresis followed by ethidium bromide staining. The PCR amplified fragments were purified with a Gel Band Purification Kit (Omega BioTek, Norcross, GA), cloned into the pMD 18-T vector (TaKaRa), and sequenced in triplicate using an ABI 3730 Sanger-based genetic analyzer (Carlsbad, CA).
Sequence Alignment and Phylogenetic Analysis
The DNA sequences of CIAV were assembled with the aid of DNAStar software version 6.0 (DNAStar Inc., Madison, WI). Multiple sequence alignment was performed using Clustal W (BioEdit version 7) and the comparison of sequence identity was performed using MegAlign software (DNAStar). A neighbor joining (NJ) tree based on the full-length nucleic acid was constructed by the MEGA 5.1 program. The robustness of the NJ tree was evaluated by a bootstrap analysis with 1,000 replicates. Evolutionary distances were computed using the pairwise distance method using a maximum composite likelihood model. Our dataset also included 28 full-length CIAV genome sequences from GenBank (Table 1) .
Identification of CIAV Genomic Recombination
Detection of potential recombination events in the CIAV genomes was performed using the Recombination Detection Program (RDP4) software (Martin, 2009 ). Furthermore, we identified the recombination events in CIAV-F10 with 9 different methods as follows: RDP, GENECONV, BootScan, MaxChi, Chimaera, SiScan, Phyl-Pro, LARD, and 3Seq (Martin et al., 2005a,b) . 
RESULTS
Identification of CIAV in the Live-Virus Vaccine Samples
PCR was used for the detection of CIAV in the 14 batches of live-virus vaccine samples. From this analysis, a total of 2 batches of live-virus vaccine samples were identified to be PCR positive for CIAV, which were obtained from vaccine samples #10 and #22 as shown in Figure 1 . CIAV was not detected in the other vaccine samples.
Testing of Live-Virus Vaccines for CIAV Contamination
The suspected CIAV-contaminated samples were inoculated into chickens that were then kept under daily observation for 6 wk post-inoculation. Serum samples were collected at 42 d post-inoculation and tested for anti-CIAV antibodies or CIAV DNA using ELISA and PCR, respectively. As shown in Table 2 , 2 groups of chickens (from vaccine #10, a live NDV vaccine and vaccine #22, a live FPV vaccine) were positive for CIAV-specific antibodies and yielded PCR products of the expected length of approximately 843 bp at 42 d post-inoculation, whereas the chickens of the negative control group were negative for CIAV-specific antibodies and PCR amplification. These results indicated that the NDV and FPV vaccines were contaminated with exogenous CIAV strains.
Molecular Characteristics and Phylogenetic Analysis of CIAV
We utilized 3 primer pairs with ExTaq DNA polymerase to amplify the 2 CIAV genomes and successfully obtained target fragments of the expected lengths. The 3 target fragments containing overlapped regions were spliced using DNASTAR software. The CIAV genome sequences amplified from the 2 vaccines were the same as those that had been amplified from the serum samples. The complete genome sequences of CIAV-F10 and CIAV-N22 strains were obtained and Table 2 . Results of ELISA and PCR analysis for the detection of CIAV antibodies and antigens in the sera of SPF chickens 42 d post-inoculation with 2 vaccine samples (#10 and #22). submitted to GenBank under the accession numbers KU845735 and KU845734, respectively. The lengths of the CIAV-F10 and CIAV-N22 strain genomes were both 2,298 bp. The complete sequences of the VP1, VP2, and VP3 genes were 1350, 651, and 366 nucleotides long, respectively, and contained no insertions or deletions. The nucleotide sequence identities between the CIAV-F10, CIAV-N22, and the 28 CIAV strains from GenBank ranged from 94.7% to 98.8% and from 94.7% to 98.7%, respectively. The highest identities with CIAV-F10 and CIAV-N22 were to the CAV-18 strain (accession no. KJ728827), which had been isolated from Taiwan in 2014 and the AH4 strain (accession no. DQ124936), which was isolated from China (Tianjin Province) in 2005. Both strains exhibited the least identity to strain CAV-14 (accession no. KJ728824), which was isolated from Taiwan in 2014.
Compared to the other available CIAV sequences in the VP1 gene region, we identified 6 amino acid mutations (at positions 3, 5, 21, 22, 288, 289) from CIAV-F10 and 3 (at positions 288, 289, 293) from CIAV-N22 that had not been described previously. No mutations were identified in the VP2 and VP3 sequences of the CIAV-F10 and CIAV-F22 strains. Thus, compared with the VP1 sequences, those of VP2 and VP3 were relatively conserved.
Phylogenetic analysis of the 2 strains characterized in this study based on their complete CIAV genome sequences together with those of the 28 available CIAV strains from different countries also suggested that the CIAV-F10 and CIAV-N22 strains were most closely related to KJ728827 and DQ124936, respectively (Figure 2 ).
Recombination Analysis of CIAV Using RDP4
Recombination detection analysis of the 30 CIAV genome sequences was performed using the RDP4 program, from which only recombination events that were supported by at least 5 independent methods were regarded as reliable.
The results showed that CIAV-F10 represented a potential recombinant strain between 2 CIAV strains; namely, CIAV strain KJ728816 as the minor parent and CIAV strain JQ690762 as the major parent with the recombination breakpoints mapping to position 1704 (beginning breakpoint) and 524 (ending breakpoint). In addition, the recombination was supplemented and supported following further analysis of the recombinant minor parent and major parent sequences through identification of the 2 points of crossover using Boot Scan (Figure 3 ).
DISCUSSION
CIAV is an economically important pathogen worldwide owing to its highly immunosuppressive effect. In recent years, the positivity rate of serum CIAV antibody detection among chicken populations in China has continued to increase, especially among local breeds (Eltahir et al., 2011a; Zhang et al., 2013) . Apart from vertical and horizontal transmission mechanisms, CIAV contamination in the attenuated vaccines used for poultry might represent an important route for the epidemic, as the initial report of CIAV was derived from contaminated vaccines in Japan (Yuasa et al., 1979) . Therefore, to identify whether any exogenous CIAV existed in live-virus vaccines used in China, 14 batches of live-virus vaccines were tested by PCR in the current study and the positive findings for 2 batches of vaccine were confirmed upon subsequent testing in SPF chickens. From these, 2 exogenous CIAV strains, designated CIAV-N22 and CIAV-F10, were identified.
The full genome sequences of the 2 identified CIAV strains were sequenced and analyzed. Comparison of the 2 strains with the published 28 CIAV genomes derived from strains isolated from across the world identified several amino acid variants that had not previously been reported. The VP2 and VP3 sequences of the CIAV-F10 strain and the CIAV-F22 strain contained no unique amino acid mutations; however, 6 and 3 previously unreported amino acid mutations in the VP1 protein of the CIAV-F10 and CIAV-F22 strains, were identified, respectively. Thus, the genome sequences of VP2 and VP3 appeared to be relatively conserved compared with those of VP1. Notably, the amino acid at position 394 in VP1 had been reported to be a major genetic determinant of virulence (Yamaguchi et al., 2001) . The 2 strains in our study exhibited a Q at position 394, which indicated that they represented highly pathogenic viruses. In addition, the amino acids at po- sitions 139 and 144 have been found to play vital roles in virus growth and spreading (Renshaw et al., 1996) . However, the presence of Q139 and Q144 in both of the identified strains indicated that these strains demonstrated low rates of growth and spread.
Phylogenetic analysis based on the complete CIAV genome sequences suggested that CIAV-F10 and CIAV-N22 shared the highest level of nucleotide sequence identity with the CAV-18 and AH4 strains of CIAV, respectively. This analysis also showed that the identified strains belonged to the same sub-branch (Figure 2) . The CAV-18 strain was isolated from Taiwan in 2014 and the AH4 strain was isolated from China in 2005, strongly suggesting that CAV-18 and AH4 were likely to be responsible for the observed CIAV infection via the contaminated vaccine. Future studies are warranted to further characterize the phylogenetic relationship between the CIAV-F10 and CIAV-N22 with the CAV-18 and AH4 strains.
Recombination might represent one of the important mechanisms underlying the generation of genetic variation in CIAV. Recombination also has important implications for detection and vaccination strategies. As a DNA virus, CIAV has rarely been found to undergo gene recombination. However, Eltahir et al. (2011b) reported the genetic recombination of CIAV in the coding regions and Zhang et al. (2013) further reported CIAV recombination events occurring in non-coding regions. In the current study, recombination analysis identified CIAV-F10 as being highly likely to have resulted from a potential recombination event between JQ690762 and KJ728816. We speculated that recombination might have and effect on the virus. (Zhang et al., 2014) . Given the high prevalence of CIAV infection, further analysis of the pathogenicity of the recombinant virus needs to be conducted.
In summary, we successfully identified the CIAV-F10 and CIAV-N22 strains from live NDV and FPV vaccines, respectively, utilized in China. The results indicated that the vaccination of CIAV-contaminated vaccines likely contributed to the prevalence and spread of CIAV infection in chickens and suggest that CIAV detection should be included among the list of regular monitoring procedures for exogenous viral contamination of attenuated poultry vaccines.
